EXELA PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EXELA PHARMA, and what generic alternatives to EXELA PHARMA drugs are available?
EXELA PHARMA has twenty-three approved drugs.
There are seventeen US patents protecting EXELA PHARMA drugs.
Summary for EXELA PHARMA
US Patents: | 17 |
Tradenames: | 20 |
Ingredients: | 20 |
NDAs: | 23 |
Patent Litigation for EXELA PHARMA: | See patent lawsuits for EXELA PHARMA |
Drugs and US Patents for EXELA PHARMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exela Pharma | ELCYS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 210660-001 | Apr 16, 2019 | RX | Yes | Yes | 11,510,942 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Exela Pharma | ELCYS | cysteine hydrochloride | SOLUTION;INTRAVENOUS | 210660-001 | Apr 16, 2019 | RX | Yes | Yes | 10,478,453 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Exela Pharma | SODIUM BICARBONATE | sodium bicarbonate | INJECTABLE;INJECTION | 211091-001 | Jun 20, 2019 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Exela Pharma | DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5% | diltiazem hydrochloride | SOLUTION;INTRAVENOUS | 215252-002 | Oct 28, 2021 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Exela Pharma | MAGNESIUM SULFATE | magnesium sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 206039-001 | Dec 18, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Exela Pharma | POTASSIUM ACETATE | potassium acetate | INJECTABLE;INJECTION | 206203-001 | Dec 29, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.